Seeking Alpha
  • Today - Friday, March 27, 2015

  • 5:19 PM
    | Comment!
  • 4:18 PM
    • Tofutti Brands (NYSEMKT:TOF): FY'14 EPS of -$0.03 vs. -$0.18 in FY'13
    • Revenue of $14.35M (-2.4% Y/Y).
    • Press Release
    | Comment!
  • 2:39 PM
    • Central Federal Corporation (NASDAQ:CFBK): Q4 EPS of $0.01 vs. $0.05 in 4Q13
    • Revenue of $2.92M (+3.5% Y/Y).
    • Press Release
    | Comment!
  • 1:21 PM
    • ChinaCache's (NASDAQ:CCIH) Q4 revenue of $54.6M missed a $60.1M consensus, and EPS of -$0.05 missed a -$0.04 consensus. In addition, Q1 revenue guidance of RMB340M-RMB350M ($54.7M-$56.3M) is below a sole analyst estimate (possibly outdated) of $77.4M, and full-year revenue growth guidance of 25%-30% is below a 33.7% 2-analyst consensus.
    • However, a lot has been priced in over the last 12 months. At the midpoint of its 2015 guidance range, ChinaCache only trades for 0.7x forward sales after backing out cash/investments.
    • Soft Q4 sales (-9.7% Q/Q and -0.2% Y/Y) are blamed on "bandwidth and service capacity interruption as customers continue to migrate onto the next-generation HPCC platform in the fourth quarter of 2014 as compared with the previous quarter." ChinaCache, which faces competition from Alibaba and others, expects the migration to be finished by the end of Q1.
    • Gross margin fell to 30% from Q3's 30.3% and Q4 2013's 31.6%. Sales/marketing spend fell 23.3% Y/Y to $4.7M and R&D 8% to $4.5M. Excluding a non-cash bad debt provision, G&A spend fell 5% to $6.7M.
    • Q4 results, PR
    | Comment!
  • 11:20 AM
    • Initially down premarket in response to its mixed FQ4 results, BlackBerry (NASDAQ:BBRY) is now moving higher.
    • Hardware (lower-margin) was 42% of revenue in FQ4 vs. 46% in FQ3; services was 47% vs. 46%, and software was 10% vs. an 8% FQ3 contribution for software/other. John Chen stated on the CC software revenue grew 24% Q/Q and 20% Y/Y - the company has previously forecast its software revenue will double in FY16 (ends Feb. '16), and its services revenue fall by 50%.
    • Gross margin fell to 48.3% from FQ3's 51.7% and the year-ago period's 56.7%. Sales/marketing/admin spend fell 52% Y/Y to $172M, and R&D spend 46% to $134M.
    • North American revenue -31% Y/Y to $205M; EMEA -31% to $283M; Latin America -53% to $60M; Asia-Pac -20% to $112M. End-user phone sales fell to 1.6M from FQ3's 1.9M and the year-ago period's 3.4M.
    • BlackBerry's cash balance rose by $156M Q/Q to $3.27B, thanks partly to an $80M net gain on acquisitions/divestitures. Long-term debt stood at $1.7B. The company still expects to reach "sustainable non-GAAP profitability" at some point in FY16.
    • Initial sell-side reactions are cautious. RBC (Sector Perform) notes services revenue fell 15% Q/Q, and thinks the drop "may continue to sustain lingering concerns about BlackBerry’s declining subscriber base.” Multiple analysts observe phone shipments (1.3M) missed estimates. Cowen (Market Perform): "The magnitude of the Hardware miss suggests smartphones may prove a less significant F2016 growth driver than expected."
    • Prior BlackBerry earnings coverage
    | 33 Comments
  • 10:46 AM
    | Comment!
  • 9:33 AM
    • Minerva Neurosciences (NERV) Q4 results: Revenues: $0; R&D Expense: $3M (+999%); SG&A: $4.5M (+136.8%); Net Loss: ($7.4M) (-252.4%); Loss Per Share: ($0.40) (+2.4%).
    • FY2014 results: Revenues: $0; R&D Expense: $42.9M (+999%); SG&A: $12M (+380.0%); Net Loss: ($56.9M) (-999%); Loss Per Share: ($4.47) (-473.1%); Quick Assets: $18.5M (+927.8%).
    • No guidance given.
    | Comment!
  • 9:28 AM
    • Atlantic American Corporation (NASDAQ:AAME): Q4 EPS of $0.06
    • Revenue of $40.92M (+0.2% Y/Y)
    • Press Release
    | Comment!
  • 9:23 AM
    • Carnival (NYSE:CCL): FQ1 EPS of $0.20 beats by $0.10.
    • Revenue of $3.53B (-1.4% Y/Y) misses by $40M.
    • Shares +4.7% PM.
    • Press Release
    | Comment!
  • 9:12 AM
    • NF Energy (NASDAQ:NFEC): FY14 EPS of -$0.61
    • Revenue of $9.98M (+75.8% Y/Y)
    • Press Release
    | Comment!
  • 9:06 AM
    • Intersections (NASDAQ:INTX): Q4 EPS of -$1.19
    • Revenue of $56.56M (-21.5% Y/Y)
    • Press Release
    | Comment!
  • 8:49 AM
    • Heat Biologics (HTBX -2.5%) FY14 results: Revenues: $0; R&D Expense: $2.9M (+7.4%); SG&A: $4M (+66.7%); Operating Loss: ($12.2M) (-84.8%); Net Loss: ($11.8M) (-29.7%); Loss Per Share: ($1.83) (+24.4%); Quick Assets: $3.7M (-19.6%).
    • No guidance given.
    | Comment!
  • 8:40 AM
    • Onconova Therapeutics (ONTX -0.8%) Q4 results: Revenues: $0.1M (-94.7%); R&D Expense: $10.4M (-14.0%); SG&A: $3.1M (-29.5%); Net Loss: ($13.4M) (+8.2%); Loss Per Share: ($0.62) (+8.8%).
    • FY2014 results: Revenues: $0.8M (-83.3%); R&D Expense: $49.4M (-1.6%); SG&A: $15.1M (-10.1%); Net Loss: ($63.7M) (+1.8%); Loss Per Share: ($2.94) (+52.0%); Quick Assets: $43.6M (-56.4%).
    • No guidance given.
    | Comment!
  • 8:39 AM
    • MOL Global (NASDAQ:MOLG): Q4 EPS of -$0.17 per ADS.
    • Revenue of $17.45M (+28.1% Y/Y).
    • Shares +2.94% PM.
    • Press Release
    | Comment!
  • 8:35 AM
    | Comment!
  • 8:16 AM
    • Cara Therapeutics (CARA -3%) Q4 results: Revenues: $0.9M (-10.0%); R&D Expense: $3.5M (+75.0%); SG&A: $1.8M (+63.6%); Operating Loss: ($4.3M) (-104.8%); Net Loss: ($4.2M) (-100.0%); Loss Per Share: ($0.18) (+63.3%).
    • FY2014 results: Revenues: $3.2M (-73.3%); R&D Expense: $15.1M (+73.6%); SG&A: $6.2M (+77.1%); Operating Loss: ($18.1M) (-999%); Net Loss: ($17.7M) (-471.0%); Loss Per Share: ($0.85) (-14.9%); Quick Assets: $52.6M (+324.2%).
    • No guidance given.
    | Comment!
  • 8:03 AM
    • Netlist (NASDAQ:NLST): Q4 EPS of -$0.14 misses by $0.02.
    • Revenue of $2.52M (-67.4% Y/Y) beats by $0.02M.
    • Press Release
    | Comment!
  • 8:00 AM
    • OncoGenex Pharmaceuticals (OGXI -2.6%) Q4 results: Revenues: $5.7M (-33.7%); R&D Expense: $9.9M (-25.0%); SG&A: $2.7M (+12.5%); Operating Loss: ($6.7M) (+4.3%); Net Loss: ($5.7M) (+14.9%); Loss Per Share: ($0.26) (+42.2%).
    • FY2014 results: Revenues: $27.1M (-9.4%); R&D Expense: $46.2M (-16.5%); SG&A: $10.6M (+7.1%); Operating Loss: ($29.5M) (+16.4%); Net Loss: ($26.2M) (+17.6%); Loss Per Share: ($1.45) (+33.2%); Quick Assets: $47.3M (+19.7%).
    • No guidance given.
    | Comment!
  • 7:56 AM
    • Cnooc (NYSE:CEO) reports a 6.5% increase in full-year profit, attributing cost cuts and higher output that helped offset the slide in global oil prices.
    • China's biggest offshore energy explorer says its net income rose to 60.2B yuan ($9.7B) from 56.5B yuan a year earlier, well ahead of the analyst consensus estimate of 52.3B yuan, but sales slipped 4% to 275B yuan.
    • Cnooc credits much of its improved profit to a 6% drop in its production cost to $42.30/boe, even while its oil and gas output rose 5.1% Y/Y to 432M boe, as more than 10 new projects started production, including Liwan 3-1, the first major deepwater gas field offshore China.
    • Cnooc says it achieved a reserve replacement ratio of 112% last year, and had net proven reserves of 4.48B boe at year-end.
    • Cnooc has said it plans to increase production by as much as 15% in 2015, while cutting capital expenditure by as much as 35% to 70B yuan.
    | 2 Comments
  • 7:48 AM
    • Loxo Oncology (LOXO +3.1%) Q4 results: Revenues: $0; R&D Expense: $4.7M (+213.3%); SG&A: $2.4M (+500.0%).
    • FY2014 results: Revenues: $0; R&D Expense: $14.5M (+49.5%); SG&A: $6.2M (+933.3%); Net Loss: ($20.7M) (-101.0%); Loss Per Share: ($3.06) (+95.7%); Quick Assets: $106.3M (+608.7%).
    • No guidance given.
    | Comment!
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs